ClinicalTrials.Veeva

Menu

Activation of Biobank Registry for Bilio-pancreatic Diseases (BIO-PANCREAS)

S

San Donato Group (GSD)

Status

Enrolling

Conditions

Non-Neoplastic Pancreatic Disorder
Pancreatic Adenocarcinoma
Pancreatitis
Pancreatic Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06552078
BIO-PANCREAS

Details and patient eligibility

About

The purpose of establishing the biobank is to create a collection of biological material and clinical data, with a prospective and retrospective mold, in order to investigate the role of genetic predisposition in multifactorial bilio-pancreatic diseases, so that an evaluation of the possible association in the pathogenesis of exogenous factors with endogenous factors can be allowed.

Multifactorial diseases are in fact an expression of genetic predisposition upon which one or more environmental stimuli act. Usually the aforementioned factors are not capable individually of triggering disease but, when simultaneously present, can cause the pathological phenotype. Therefore, it becomes important in the description of disease pathogenesis to identify as many risk factors for disease prevention and early diagnosis.

Full description

Samples collected depending on the disease:

  • Peripheral blood;
  • Portal blood;
  • Saliva;
  • Urine;
  • Stool;
  • Cystic fluid;
  • Pancreatic juice;
  • Biopsy tissue specimens;

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age >= 18 years
  • signed informed consent

Exclusion criteria

  • age < 18 years
  • unwilling to sign informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Gabriele Capurso, MD; Laura Apadula, MSN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems